Sustained improvement of psoriasis associated with HCV after virologic response to sofosbuvir/ribavirin

被引:5
|
作者
Elfert, Asem Ahmed [1 ]
机构
[1] Tanta Univ, Fac Med, Dept Trop Med & Infect Dis, Tanta, Egypt
关键词
HCV; Extrahepatic manifestations; Psoriasis; Sofosbuvir; Ribavrin;
D O I
10.1016/j.ajg.2017.09.002
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
An 18 year old boy attended a dermatology clinic outside our hospital and diagnosed with psoriasis. His skin lesions over both ankles (Fig. 1) did not improve at all with potent local steroids twice for 3 months, then 3 times daily for another 3 months. His dermatologist talked to him about using methotrexate and asked for liver function tests before starting the systemic therapy. His ALT and AST were doubled. The patient came to our Hepatology clinic worried about his elevated liver enzymes. We asked for viral markers. His HCV-Ab was positive, and PCR for HCV-RNA was 650,000 IU/ml. Treatment started with sofosbuvir 400 mg PO once daily plus ribavirin 600 mg at the morning and 400 mg at the evening. After 4 weeks, ALT and AST decreased to normal and PCR for HCV-RNA was <5 IU/ml. All other lab tests were unremarkable. The skin lesions improved markedly (Fig. 2). Now, after 6 months of the end of treatment, sustained virologic response was documented and the skin lesions are almost disappeared without any topical or systemic treatment. © 2017 Pan-Arab Association of Gastroenterology
引用
收藏
页码:234 / 234
页数:1
相关论文
共 50 条
  • [41] EVALUATION OF HCV RNA DECAY 48 HOURS AFTER STARTING COMBINATION THERAPY WITH PEGILATED INTERFERON AND RIBAVIRIN AS A TOOL FOR EARLY PREDICTION OF SUSTAINED VIROLOGIC RESPONSE
    Parruti, Giustino
    Sozio, Federica
    Pieri, Alessandro
    Polilli, Ennio
    Di Masi, Francesco
    Cosentino, Luana
    Alterio, Luciana
    Manzoli, Lamberto
    HEPATOLOGY, 2009, 50 (04) : 697A - 697A
  • [42] SUSTAINED VIROLOGIC RESPONSE 15 INDEPENDENTLY ASSOCIATED WITH IMPROVEMENT IN INSULIN RESISTANCE IN GENOTYPE 1, BUT NOT GENOTYPE 2/3, CHRONIC HCV PATIENTS
    Thompson, Alexander J.
    Patel, Keyur
    Tillmann, Hans L.
    McCarthy, Jeanette
    Zeuzem, Stefan
    Benhamou, Yves
    Nelson, David R.
    Sulkowski, Mark S.
    Torbenson, Michael
    Pulkstenis, Erik
    Subramanian, G. M.
    McHutchison, John G.
    HEPATOLOGY, 2009, 50 (04) : 358A - 359A
  • [43] Achievement of Sustained Virologic Response in HCV-Infection Treatment after Liver Transplantation.
    Yaroshenko, Ekaterina B.
    Kornilov, Maxim N.
    Moysyuk, Yan G.
    LIVER TRANSPLANTATION, 2013, 19 : S147 - S147
  • [44] Persistence of Virologic Response after Liver Transplant in Hepatitis C Patients Treated with Ledipasvir/Sofosbuvir Plus Ribavirin Pretransplant
    Vinaixa, Carmen
    Berenguer, Marina
    ANNALS OF HEPATOLOGY, 2017, 16 (03) : 322 - 323
  • [45] Adherence to the 80/80/80 rule in treatment of HCV recurrence after OLT is strongly associated with sustained virologic response (SVR)
    Chacko, Kristina
    Sussman, Norman
    Vierling, John M.
    Goss, John
    Barshes, Neal R.
    Stribling, Rise
    O'Mahony, Christine
    HEPATOLOGY, 2006, 44 (04) : 482A - 482A
  • [46] HCV genotype does not predict sustained virologic response to interferon plus ribavirin in chronic hepatitis C patients with advanced fibrosis
    Cheinquer, H
    Coelho-Borges, S
    Cheinquer, N
    Sander, G
    Rezende, V
    Hadlich, E
    Stifft, J
    JOURNAL OF HEPATOLOGY, 2002, 36 : 230 - 230
  • [47] RELATIONSHIP BETWEEN INSULIN RESISTANCE (IR) AND SUSTAINED VIROLOGIC RESPONSE (SVR) IN THE TREATMENT OF HEPATITIS C VIRUS (HCV) WITH INTERFERON AND RIBAVIRIN
    Cassidy, William M.
    Horswell, Ronald
    HEPATOLOGY, 2008, 48 (04) : 889A - 889A
  • [48] SUSTAINED VIROLOGICAL RESPONSE IN HCV PATIENTS TREATED WITH DACLATASVIR plus SOFOSBUVIR, WITH OR WITHOUT RIBAVIRIN: A MULTICENTER, FIELD-PRACTICE EXPERIENCE
    Sacco, Rodolfo
    Salomoni, Elena
    Parodi, Sara
    Gianni, Elena
    Gragnani, Laura
    Andreotti, Giovanni
    Zignego, Anna Linda
    Gattai, Riccardo
    Vivaldi, Ilo
    De Luca, Andrea
    Bartolozzi, Dario
    Cinelli, Roberta
    Pozzi, Marco
    Coco, Barbara
    Tapete, Gherardo
    Forte, Paolo
    Puntili, Rachele
    Ricciardi, Liana
    Sani, Spartaco
    Luchi, Sauro
    Brunetto, Maurizia Rossana
    Valoriani, Beatrice
    Riccardi, Maria Piera
    Nencioni, Cesira
    Aquilini, Donatella
    Nerli, Alessandro
    Esperti, Francesco
    Mazzotta, Francesco
    Fabiani, Silvia
    Menichetti, Francesco
    Bresci, Giampaolo
    Colombatto, Piero
    GASTROENTEROLOGY, 2017, 152 (05) : S1097 - S1097
  • [49] Sustained virological response in HCV patients treated with daclatasvir plus sofosbuvir, with or without ribavirin: a multicenter, field-practice experience
    Sacco, R.
    Salomoni, E.
    Parodi, S.
    Gianni, E.
    Gragnani, L.
    Andreotti, G.
    Brunetto, M. R.
    Zignego, A. L.
    Gattai, R.
    Vivaldi, I.
    De Luca, A.
    Bartolozzi, D.
    Cinelli, R.
    Pozzi, M.
    Coco, B.
    Tapete, G.
    Forte, P.
    Puntili, R.
    Ricciardi, L.
    Sani, S.
    Luchi, S.
    Valoriani, B.
    Riccardi, M. P.
    Nencioni, C.
    Aquilini, D.
    Nerli, A.
    Esperti, F.
    Mazzotta, F.
    Bresci, G.
    Colombatto, P.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S734 - S734
  • [50] Improvement of Central and Peripheral Fatigue and Associated Biomarkers After Sustained Virologic Response (SVR) With Ledipasvir (LDV)/Sofosbuvir (SOF) in Patients With Chronic Hepatitis C Virus (CH-C)
    Gerber, Lynn
    Estep, James M.
    Elsheikh, Elzafir
    Stepanova, Maria
    Escheik, Carey
    Younossi, Zobair M.
    GASTROENTEROLOGY, 2015, 148 (04) : S1014 - S1014